Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 12, 1999, Pages 1107-1110

  Platz, Elizabeth A ^a,d   Pollak, Michael N ^c   Rimm, Eric B ^a,b   Majeed, Noreen ^c   Tao, Yuzhen ^c   Willett, Walter C ^a,b   Giovannucci, Edward ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; ETHNIC GROUP; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLLOW-UP STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; STATISTICS, NONPARAMETRIC; UNITED STATES;

EID: 0033432699     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Parker, S. L., Davis, K. J., Wingo, P. A., Ries, L. A. G., and Health, C. W., Jr. Cancer statistics by race and ethnicity. CA Cancer J. Clin., 48: 31-48, 1998.
2. Parkin, D. M., Muir, C. S., Whelan, S. L., Gao, Y. T., Ferlay, J., and Powell, J. Cancer Incidence in Five Continents. Lyon, France: IARC, 1992.
3. Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., and Pollak, M. Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science (Washington DC), 279: 563-566, 1998.
4. Mantzoros, C. S., Tzonou, A., Signorello, L. B., Stampfer, M., Trichopoulos, D., and Adami, H. O. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br. J. Cancer, 76: 1115-1118, 1997.
5. Wolk, A., Mantzoros, C. S., Andersson, S. W., Bergström, R., Signorello, L. B., Lagiou, P., Adami, H. O., and Trichopoulos, D. Insulin-like growth factor I and prostate cancer risk: a population-based, case-control study. J. Natl. Cancer Inst., 90: 911-915, 1998.
6. Cohen, P., Peehl, D. M., and Rosenfeld, R. G. The IGF axis in the prostate. Horm. Metab. Res., 26: 81-84, 1994.
7. Cohen, P., Peehl, D. M., Lamson, G., and Rosenfeld, R. G. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J. Clin. Endocrinol. Metab., 73: 401-407, 1991.
8. Leroith, D., and Roberts, C. T., Jr. Growth factors and cytokines. In: K. Becker (ed.), Principles and Practice of Endocrinology and Metabolism, pp. 1451-1465. Philadelphia: JB Lippincott Co, 1995.
9. Rajah, R., Valentinis, B., and Cohen, P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem., 272: 12181-12188, 1997.
10. Ross, R. K., Bernstein, L., Lobo, R. A., Shimizu, H., Stanczyk, F. Z., Pike, M. C., and Henderson, B. E. 5-α-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet, 339: 887-889, 1992.
11. Tricoli, J. V., Winter, D. L., Hanlon, A. L., Raysor, S. L., Watkins-Bruner, D., Pinover, W. H., and Hanks, G. E. Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer. Urology, 54: 178-182, 1999.
12. Wright, N. M., Papadea, N., Willi, S., Veldhuis, J. D., Pandey, J. P., Key, L. L., and Bell, N. H. Demonstration of a lack of racial difference in secretion of growth hormone despite a racial difference in bone mineral density in premenopausal women-a clinical research study center. J. Clin. Endocrinol. Metab., 81: 1023-1026, 1996.
13. Hopkins, K. D., Lehmann, E. D., Jones, R. L., Holly, J. M., Cwyfan-Hughes, S. C., Turay, R. C., Teale, J. D., and Gosling, R. G. Ethnicity affects IGFBP-3 and IGF-II in normal healthy young adult subjects. Clin. Endocrinol., 45: 327-331, 1996.
14. Goodman-Gruen, D., and Barren-Connor, E. Epidemiology of insulin-like growth factor-I in elderly men and women: the Rancho Bernardo Study. Am. J. Epidemiol., 145: 970-976, 1997.
15. Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., and Wu, X. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J. Natl. Cancer Inst., 91: 151-156, 1999.
16. Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., and Pollak, M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351: 1393-1396, 1998.
17. Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y. Z., Hennekens, C. H., and Stampfer, M. J. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst., 91: 620-625, 1999.
18. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1999. CA Cancer J. Clin., 49: 8-31, 1999.